Skip to main content
. 2016 Jan 25;6:20035. doi: 10.1038/srep20035

Figure 2. Cisplatin treatment of MSCs results in G2 phase arrest but no increase in apoptosis.

Figure 2

Cell cycle distribution of two MSC samples (a) and two fibroblast cell lines (b) after 4-hour treatment with 1000 ng/mL cisplatin. (c,d) Percentage of apoptotic MSC1, MSC2 stem cells and HS68 and MRC5 fibroblasts after 1000 ng/mL cisplatin as assessed by sub-G1 population and caspase-3 activation. Error bars represent standard deviation (n = 3). *P < 0.05, **P < 0.01.